Skip to main content
. 2020 Apr 30;6(6):1–8. doi: 10.1001/jamaoncol.2020.0930

Table 1. Best Overall Response and Disease Control Rate.

Best overall response No. (%) (n = 46)
RECIST, version 1.1 iRECIST
Investigator review Central review Investigator review Central review
CR (iCR) 0 0 0 0
PR (iPR) 10 (22) 5 (11) 10 (22) 6 (13)
1 Unconfirmed 1 Unconfirmed 1 Unconfirmed 1 Unconfirmed
SD (iSD) 17 (37) 18 (39) 18 (39) 22 (48)
PD (iUPD + iCPD) 19 (41) 23 (50) 18 (39) 18 (39)
Disease control rate 27 (59) 23 (50) 28 (61) 28 (61)

Abbreviations: CR, complete response; iCPD, immune confirmed progressive disease; iCR, immune complete response; iPR, immune partial response; iRECIST, immunotherapy Response Evaluation Criteria in Solid Tumors; iSD, immune stable disease; iUPD, immune unconfirmed progressive disease; PD, progressive disease; PR, partial response; RECIST, Response Evaluation Criteria in Solid Tumors; SD, stable disease.